What did the 1966 national drug policy in South Africa aim to do?

What did the 1966 national drug policy in South Africa aim to do?

• A. Ensure comprehensive access to and rational use of essential drugs
• B. Phase out essential drugs from the public sector
• C. Provide drugs only to private sector patients
• D. Shift all drug procurement to international suppliers

Answer: (A)

The main idea being tested is the goal of a national drug policy to ensure that essential medicines are available to the whole population and used wisely. In 1966 South Africa aimed to secure comprehensive access to a defined list of essential drugs, while also promoting their rational use—meaning medicines prescribed and dispensed appropriately, in the right doses and durations, for the right patients, and with attention to safety and cost. This combination enhances health outcomes by making needed medicines accessible and by avoiding waste, misuse, or overuse. Why this fits best is that it directly addresses both availability and proper use, the two pillars of an effective essential medicines approach. The other options conflict with this aim: phasing out essential drugs would undermine the core concept of prioritizing those medicines; limiting drugs to the private sector would create inequities in access; and shifting procurement entirely to international suppliers doesn’t by itself ensure access or rational use within the population.

The main idea being tested is the goal of a national drug policy to ensure that essential medicines are available to the whole population and used wisely. In 1966 South Africa aimed to secure comprehensive access to a defined list of essential drugs, while also promoting their rational use—meaning medicines prescribed and dispensed appropriately, in the right doses and durations, for the right patients, and with attention to safety and cost. This combination enhances health outcomes by making needed medicines accessible and by avoiding waste, misuse, or overuse.

Why this fits best is that it directly addresses both availability and proper use, the two pillars of an effective essential medicines approach. The other options conflict with this aim: phasing out essential drugs would undermine the core concept of prioritizing those medicines; limiting drugs to the private sector would create inequities in access; and shifting procurement entirely to international suppliers doesn’t by itself ensure access or rational use within the population.